IL-1-mediated inhibition of IL-6-induced STAT3 activation is modulated by IL-4, MAP kinase inhibitors and redox state of HepG2 cells

Folia Histochemica et Cytobiologica

Volumn 40, Issue 4, 2002, Pages 341-345

  Cisowski, Jarosław ^a   Zarebski, Adrian ^a   Koj, Aleksander ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Antioxidants; IL 1; IL 4; IL 6; MAP kinase inhibitors; NF B; STAT

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALLING PROTEIN 3; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; DNA BINDING PROTEIN; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG RESPONSE; HEPATOMA CELL; HUMAN; HUMAN CELL; METABOLIC ACTIVATION; METABOLIC INHIBITION; MOLECULAR INTERACTION; OXIDATION REDUCTION STATE; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; CLASSIFICATION; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM; OXIDATION REDUCTION REACTION;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATION-REDUCTION; PYRIDINES; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0036028827     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270: 27489-27494
2. Ahmed ST, Ivashkiv LB (2000) Inhibition of IL-6 and IL-10 signaling and STAT activation by inflammatory and stress pathways. J Immunol 165: 5227-5237
3. Bode JG, Gatsios P, Ludwig S, Rapp UF, Haussinger D, Heinrich PC, Graeve L (1999) The mitogen activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity. J Biol Chem 272: 10212-10227
4. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M (1997) Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16: 295-305
5. Doszczak MM, Pierzchalski A, Bigda J (2001) Mechanisms of interleukin-1 signal transduction (in Polish). Post Biol Kom 28: 99-127
6. Ferguson PR, Johnston JA (2001) Suppressors of cytokine signalling (SOCS) regulate cytokine and growth factor responses in the immune system. Mod Asp Immunobiol 2: 92-96
7. Finch A, Davis W, Carter WG, Saklatvala J (2001) Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinases 4 and 7. Biochem J 353: 275-281
8. Horvath CM (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25: 496-502
9. Karin M, Delhase M (2000) The IkB kinase (IKK) and NFκB: key elements in proinflammatory signalling. Semin Immunol 12: 85-98
10. Koj A, Gauldie J, Baumann H (1993) Biological perspectives of cytokine and hormone networks. In: Acute Phase Proteins, Molecular Biology, Biochemistry and Clinical Applications. Mackiewicz A, Kushner I, Baumann H [Eds], CRC Press, Boca Raton-Ann Arbor-London-Tokyo, pp 275-287
11. Koj A (1996) Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1317: 84-94
12. Orchansky PL, Kwan R, Lee F, Schrade JW (1999) Characterization of the cytoplasmic domain of interleukin-13 receptor alpha. J Biol Chem 274: 20818-20825
13. Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D, Kerr IM, Heinrich PC (1998) Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute phase response. Biochem J 335: 557-565
14. Schenk H, Klein M, Erdbrugger W, Droege W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFκB and AP-1. Proc Natl Acad Sci USA 91: 1672-1676
15. Sehgal PB (2000) STAT-signalling through the cytoplasmic compartment. Consideration of a new paradigm. Cell Signal 12: 525-535
16. Sengupta TK, Talbot ES, Scherle PA, Ivashkiv LB (1998) Rapid inhibition of interleukin-6 signaling and STAT3 activation mediated by mitogen-activated kinases. Proc Natl Acad Sci USA 95: 11107-11112
17. Shen X, Tian Z, Holtzman MJ, Gao B (2000) Cross-talk between interleukin-1β and IL-6 signalling pathways: IL-1β selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-depedent mechanism. Biochem J 352: 913-919
18. Sobota R, Szwed M, Kasza A, Bugno M, Kordula T (2000) Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family. Biochem Biophys Res Commun 267: 329-333
19. Terstegen L, Gatsios P, Bode JG, Schaper F, Heinrich PC, Graeve L (2000) The inhibition of IL-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 739 in the cytoplasmic tail of glycoprotein 130. J Biol Chem 275: 18810-18817
20. 1/IL-4α receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation. FEBS Lett 464: 91-96
21. Zhang ZX, Fuller GM (2001) Interleukin-1β inhibits interleukin-6-mediated rat gamma fibrinogen gene expression. Blood 96: 3466-3472